Showing results (1831-1840 of 2,037) with videos related to

Sort By:
Pageof 204
Clinical Epigenetics|October 23, 2020
Genetic and environmental causes of variation in epigenetic aging across the lifespanShuai Li, Tuong L Nguyen, Ee Ming Wong, et al.
European Urology|March 24, 2016
The PREVAIL Study: Primary Outcomes by Site and Extent of Baseline Disease for Enzalutamide-treated Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate CancerChristopher P Evans, Celestia S Higano, Thomas Keane, et al.
Alzheimer'S Research & Therapy|July 9, 2021
Lewy Body Dementia Association's Industry Advisory Council: proceedings of the second annual meetingJennifer G Goldman, Bradley F Boeve, Melissa J Armstrong, et al.
Prostate Cancer and Prostatic Diseases|March 11, 2022
A randomized controlled trial comparing changes in fitness with or without supervised exercise in patients initiated on enzalutamide and androgen deprivation therapy for non-metastatic castration-sensitive prostate cancer (EXTEND)Michael R Harrison, Paul G Davis, Michel G Khouri, et al.
Biomarker Research|November 4, 2021
Association of baseline neutrophil-to-eosinophil ratio with response to nivolumab plus ipilimumab in patients with metastatic renal cell carcinomaMatthew D Tucker, Landon C Brown, Yu-Wei Chen, et al.
European Urology Oncology|May 14, 2025
Patient-reported Outcomes in KEYNOTE-921: Pembrolizumab with Docetaxel and Prednisone for Patients with Metastatic Castration-resistant Prostate CancerNobuaki Matsubara, Daniel Petrylak, Raffaele Ratta, et al.
Neurology|February 15, 2018
Comprehensive systematic review summary: Treatment of cerebellar motor dysfunction and ataxia [RETIRED]: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of NeurologyTheresa A Zesiewicz, George Wilmot, Sheng-Han Kuo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentKeith N Fargo, Melissa J Armstrong, Larry J Bauer, et al.
Plos One|May 29, 2019
Pharmacodynamic study of radium-223 in men with bone metastatic castration resistant prostate cancerAndrew J Armstrong, Santosh Gupta, Patrick Healy, et al.
The Journal of Invasive Cardiology|January 6, 2019
Clinical Outcomes and Cost Comparisons of Stent and Non-Stent Interventions in Infrainguinal Peripheral Artery Disease: Insights From the Excellence in Peripheral Artery Disease (XLPAD) RegistrySubhash Banerjee, Haekyung Jeon-Slaughter, Ehrin J Armstrong, et al.
Pageof 204